Active Shortage Injection Cardiovascular
Bumetanide Injection · #10 of 35 active shortages by FDA posting duration
Brand: BUMETANIDE
FDA lists Bumetanide Injection as Active Shortage (Mullan Pharmaceutical Inc.).
Availability on file: Available
Bumetanide Injection: Active Shortage
Available 17 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Bumetanide Injection
- Manufacturer
- Mullan Pharmaceutical Inc.
- Dosage Form
- Injection
- Presentation
- Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)
- Package NDC
- 83301-0080-2
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 13, 2017
- Last Updated
- Mar 16, 2026
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
bumetanide
Side effects, interactions, warnings & more
Nearby, Other Bumetanide Shortage Records
Bumetanide Injection
Fresenius Kabi USA, LLC
Injection
Bumetanide Injection
Fresenius Kabi USA, LLC
Injection
Bumetanide Injection
Mullan Pharmaceutical Inc.
Injection
Bumetanide Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Bumetanide Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Bumetanide Injection
Sagent Pharmaceuticals
Injection